Common stock, 0.0001 par value, 250,000,000 shares authorized at june 30, 2026 and december 31, 2025 16,227,524 and 4,574,983 shares issued at june 30, 2026 and december 31, 2025, respectively 16,227,518 and 4,574,977 shares outstanding at june 30, 2026 and december 31, 2025, respectively
1,624
929
459
320
Additional paid-in capital
145,063,802
142,935,443
142,933,260
138,155,394
Accumulated deficit
-145,847,123
-143,276,414
-139,719,999
-136,952,351
Total ensysce biosciences, inc. stockholders equity (deficit)
-781,697
-340,042
3,213,720
1,203,363
Noncontrolling interests in stockholders equity (deficit)
-329,136
-328,970
-328,970
-328,649
Total stockholders equity (deficit)
-1,110,833
-669,012
2,884,750
874,714
Total liabilities and stockholders equity (deficit)
2,957,273
2,167,803
7,452,479
3,179,464
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.